About: genetic modification

Green MEP: EU’s gene editing framework stifles innovation

The EU’s regulatory framework on gene editing is insufficient and risks pushing out research and innovation from the EU, according to a Green MEP, diverging from her party’s strong stance on the matter.

Not all gene-edited crops should be treated equal, warn MEPs

There is a need to ensure a targeted approach to gene editing because not all genomic techniques confer the sustainability benefits promised in the European Commission's new study, EU lawmakers have warned.

Commission reopens gene editing’s box amid sustainability claims

A new study from the European Commission has concluded that the current legal framework governing new genomic techniques (NGTs) is insufficient and indicated that new policy instruments should be considered to reap the benefits of this technology.

Agrifood Brief: A 5-column clover for luck with CAP

Welcome to EURACTIV’s AgriFood Brief, your weekly update on all things Agriculture & Food in the EU. You can subscribe here if you haven’t done so yet.   This week: we speak with Green MEP Eleonora Evi about the differences...

Genetically modified soybean gains EU Commission approval

The European Commission authorised a genetically modified soybean for food and feed, but not cultivation, on Monday (28 September), paving the way for a full launch of the variety in the US and Canada in 2021.

UK gene editing amendment withdrawn, but government commits to consultation

An amendment tabled in the new UK agriculture bill, designed to allow access to new gene-editing technology, has been withdrawn but the government has pledged to conduct a public consultation on the issue, amid indications that it could eventually be in favour.

French MEP calls for ‘realism’ in Farm to Fork strategy

The plant protection part of the upcoming Farm to Fork strategy should take a realistic and science-based approach that allows farmers to “explore all possible solutions”, French conservative MEP Anne Sander told EURACTIV.

EU study to clarify gene editing court ruling further muddies waters

After the European Court of Justice (ECJ) ruling that organisms obtained by new plant breeding techniques (NBTs) should, in principle, fall under the GMO Directive, the Council of the EU has requested a study from the Commission to clarify the situation. But what this means in practice remains unclear.

Genetic innovation: ‘Nothing that we eat is natural’

The world is in constant need of more food and new genetic engineering methods such as the CRISPR gene editing method offer a solution. However, these remain contested, EURACTIV Germany reports.

Fresh EU-US trade spat brewing over new plant breeding techniques

EXCLUSIVE / After Europe's decision to keep its door shut to GMOs, the European Commission is trying its best to avoid opening a new trade row with the United States over how to regulate so-called 'new plant breeding techniques' (NPBTs).

Life Sciences & Biotechnology

The EU's Life Sciences and Biotech Strategy aims to make the European biotech sector more competitive and to foster research in the areas of health care, agriculture, manufacturing and the environment.

Science & Ethics

Passionate debates on biotechnology, stem cell research and cloning have shown that there is a need for open public dialogue on the ethical implications of scientific advances. With a view of furthering responsible research which respects fundamental ethical principles, the EU has taken a number of initiatives addressing ethical issues.

Genetically Modified Organisms

In response to public fears about genetically modified organisms (GMOs) in food, the European Union adopted in July 2003 two regulations establishing an EU-wide system to trace and label GMOs and to regulate the commercialisation and labelling of food derived from GMOs. These new laws came into force in April 2004. On 18 May, the Commission put an end to the 'de facto' moratorium on approving new GM products for the European market, which had been in place since 1998.

Patenting Life [Archived]

The European Union assured the legal protection of innovation in the area of biotechnology with Directive 98/44/EC on the legal protection of biotechnological inventions. The Directive established harmonised standards in order to foster the innovative potential and competitiveness of science and industry in the Union. The Directive sets out which inventions involving plants, animals or the human body may or may not be patented. It requires the Member States to allow the patenting, under certain conditions, of inventions which may have an industrial application. The Commission is currently pursuing infringement proceedings against nine Member States for their failure to transpose the Directive into national law by the 30 July 2000 deadline.